Philip D. Greenberg

Oncology
825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications

Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.

Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.

Journal: Journal for immunotherapy of cancer
Published: January 21, 2026

Guidelines for T cell nomenclature.

Guidelines for T cell nomenclature.

Journal: Nature reviews. Immunology
Published: October 03, 2025

A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy.

A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 23, 2025

Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 22, 2025

The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction.

The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction.

Journal: Nature
Published: August 29, 2025

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials.

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials.

Journal: Journal for immunotherapy of cancer
Published: May 14, 2025

Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

Journal: Science (New York, N.Y.)
Published: May 08, 2025

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Journal: Nature communications
Published: March 31, 2025

APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence.

APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence.

Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025

Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence.

Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence.

Journal: medRxiv : the preprint server for health sciences
Published: January 07, 2025

Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy.

Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy.

Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024

Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity.

Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity.

Journal: bioRxiv : the preprint server for biology
Published: September 30, 2024
Showing 1-12 of 93

Last Updated: 09/26/2026